Economic assessment of the 2020 site-neutral payment reform for dermatologists - 08/09/20
Doi : 10.1016/j.jaad.2020.02.035
Christian Gronbeck, BA a, Paula W. Feng, MD b, Hao Feng, MD, MHS c, ⁎ 
a University of Connecticut School of Medicine, Farmington, Connecticut
b Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Connecticut
c Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut
∗Correspondence to: Hao Feng, MD, MHS, Department of Dermatology, University of Connecticut Health Center, 21 South Rd, 2nd Fl, Farmington, CT 06032.Department of DermatologyUniversity of Connecticut Health Center21 South Rd2nd FlFarmingtonCT06032
| Funding sources: None. |
|
| Disclosure: Author H. Feng has served as a consultant for Cytrellis Biosystems, Inc. Authors Gronbeck and P.W. Feng have no conflicts of interest to declare. |
|
| IRB approval status: Reviewed and exempted by the University of Connecticut Health Center. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 4
P. 1196-1198 - octobre 2020 Retour au numéro
Article précédent
- Metric selection by dermatologists in the 2017 Merit-Based Incentive Payment System
- Christian Gronbeck, Paula W. Feng, Hao Feng
- Psoriasis improvement and satisfaction in patients using a clobetasol spray and oral apremilast combination regimen: A pilot study
- Chapman Wei, Adam J. Friedman, Ronald B. Prussick
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?